Joseph Piscitelli

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Low Density Lipoprotein

Cardiovascular Disease

Clinical Evaluation

Replacement Therapy

Top Venues

Clinical pharmacokinetics

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Joseph Piscitelli, Micaela B Reddy, Lance Wollenberg, Laurence Del Frari, Jason Gong, Linda Wood, Yizhong Zhang, Kyle Matschke, Jason H Williams
Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration. Clinical pharmacokinetics 63 (4) (2024)
Joseph Piscitelli, Micaela B Reddy, Lance Wollenberg, Laurence Del Frari, Jason Gong, Linda Wood, Yizhong Zhang, Kyle Matschke, Jason H Williams
Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration. Clinical pharmacokinetics 63 (4) (2024)
Joseph Piscitelli, Micaela B Reddy, Lance Wollenberg, Laurence Del Frari, Jason Gong, Linda Wood, Yizhong Zhang, Kyle Matschke, Jason H Williams
Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration. Clinical pharmacokinetics (2024)
Joseph Piscitelli, Micaela B Reddy, Lance Wollenberg, Laurence Del Frari, Jason Gong, Linda Wood, Yizhong Zhang, Kyle Matschke, Jason H Williams
Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration. Clinical pharmacokinetics 63 (4) (2024)
Joseph Piscitelli, Bart Hens, Irena Tomaszewska, Lance Wollenberg, Kevin Litwiler, Mark McAllister, Micaela B Reddy
Effect of Food and a Proton-Pump Inhibitor on the Absorption of Encorafenib: An In Vivo - In Vitro - In Silico Approach. Molecular pharmaceutics (2023)